Login / Signup

HER-2 overexpression is a negative predictive factor for recurrence in patients with non-muscle-invasive bladder cancer on intravesical therapy.

Georgios MoustakasKampantais SpyridonAnastasia NikolaidouIoannis VakalopoulosValentini TzioufaGeorgios Dimitriadis
Published in: The Journal of international medical research (2020)
Keyphrases
  • muscle invasive bladder cancer
  • cell proliferation
  • free survival
  • transcription factor
  • stem cells
  • bone marrow
  • mesenchymal stem cells
  • smoking cessation
  • replacement therapy